Trials / Unknown
UnknownNCT03456232
High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Guangdong Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on small and moderate molecule substances clearance. Meanwhile, this study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on cardiac function. In this self matching study, participants will receive high-flux hemodialysis compared to hemodiafiltration.
Detailed description
Hemodialysis using diffusion, ultrafiltration and convection principle to remove harmful substances in the blood and excessive water, is one of the most commonly replacement therapy. Hemodiafiltration is a combination of hemodialysis and hemofiltration with two modes of treatment advantages, both by diffusion and convection principle to remove harmful substances in the blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | High-flux hemodialysis | High-flux hemodialysis using diffusion, ultrafiltration and convection principle to remove harmful substances in the blood and excessive water. |
| OTHER | Hemodiafiltration | Hemodiafiltration is a combination of hemodialysis and hemofiltration with two modes of treatment advantages, both by diffusion and convection principle to remove harmful substances in the blood. |
Timeline
- Start date
- 2017-12-21
- Primary completion
- 2018-03-10
- Completion
- 2018-03-20
- First posted
- 2018-03-07
- Last updated
- 2018-03-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03456232. Inclusion in this directory is not an endorsement.